"I am so honored that my mother was the first-ever human patient to receive the
IsoFlow catheter. The IsoFlow technology represents new hope for the many, many
people that are battling cancer."
- David Martin,
son of Joan Martin
"In select clinical situations, the benefits of delivering a local endovascular
drug dose without systemic exposure can reduce complications, improve results,
and benefit patients. The IsoFlow catheter facilitates the use of regional
infusion therapies, especially in cases of challenging arterial anatomy where it
helps achieve these promises of targeted delivery. IsoFlow is a valuable
addition to our treatment arsenal."
- Dr. Michael Dake
Former Chief of Interventional Radiology & Current Professor of Cardiothoracic
Surgery
Stanford University School of Medicine - Palo Alto, California